CS MEDICA A/S: Minutes of the General Assembly
Today on February 29, 2024, in Copenhagen - CS MEDICA A/S (”CS MEDICA” or the ”Company”) held its annual general meeting (“AGM”) at which the following principal resolutions were passed.
1. Election of chairman of the meeting
The board proposed Gitte Lund Henriksen as chairman of the meeting, which was unanimously accepted by the attendees.
The chairman confirmed that the convening of the Annual General Meeting (AGM) complied with the company's Articles of Association, as stipulated in section 5.1. Notice of the AGM was duly dispatched on the 14th of February 2024, meeting the requirements of section 5.2.
It was ascertained that the total number of voting shares stood at 8,899,282 (72%), out of a total share count of 12,322,635.
2. Presentation of the annual report with auditors’ report for adoption
The AGM resolved in accordance with the Board of Directors’ proposal, to approve the annual report presented during the AGM, with all votes represented at the AGM.
3. Resolution concerning the appropriation of profits or losses as recorded in the adopted annual report
The AGM resolved, in accordance with the Board of Directors’ proposal, that the result for the period 1 October 2022 – 30 September 2023 (DKK - 14.512.764) is carried forward to the following year, with all votes represented at the AGM.
4. Election of members to the board of directors
The AGM resolved to replace two out of the four members on the board: Jørgen Flemming Ladefoged, and Karsten Adelmark. The vacant positions are now filled by Flemming Hegaard, Ib Madsen, and Jesper Halle, respectively, with Flemming Hegaard as Chairman of the Board. The decision was unanimously supported by all votes represented at the AGM.
5. Election of auditor
The AGM resolved, in accordance with the board of directors’ proposal, that the existing auditor Christensen Kjærulff Statsautoriseret Revisionsaktieselskab was re-elected. The decision was supported by all votes represented at the AGM.
8. Any other business
The Chairman ascertained that no other business was to be discussed.
For more information about CS MEDICA, please contact:
Gitte Lund Henriksen, CFO
Phone: + (45) 2774 2280
Email: glh@cs-medica.com
Website: https://www.cs-medica.com/
CS MEDICA is a Danish-based MedTech company operating within research, development, manufacturing, commercializing, and operating within the pharmaceutical industry. The company combines science and nature with the purpose of creating over-the-counter treatments to fight autoimmune and stress-related diseases, built upon our knowledge of the endocannabinoid system, patients' needs, and our experience in the pharmaceutical industry. We do so by pioneering scientific breakthroughs, expanding access to our treatments, understanding patients globally, and working to prevent the pain caused by the diseases we treat.
The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information, visit cs-medica.com and LinkedIn.
Tags: